Document Detail


Management of sickle hemoglobinopathies in pregnant patients.
MedLine Citation:
PMID:  7282804     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
During the past decade, pregnancy outcome has improved among patients with sickle hemoglobinopathies. The role of prophylactic exchange transfusion in this improvement is uncertain. This study reviews the experience in 64 pregnancies managed at the Medical University Hospital over a 7 year period. Prophylactic exchange transfusion was not associated with improved pregnancy outcome and was associated with significant antibody formation. Exchange transfusion may best be reserved as a treatment modality when infection, crisis, or symptomatic anemia occurs in patients with a sickle hemoglobinopathy.
Authors:
J M Miller; E O Horger; T C Key; E M Walker
Related Documents :
940024 - The effect of maternal partial exchange transfusion on the infants of patients with sic...
25130754 - Influence of temperament score and handling facility on stress, reproductive hormone co...
23429204 - Maternal depression, antidepressant use in pregnancy and apgar scores in infants.
17904904 - Fetal anaemia: diagnosis and management.
2447774 - Differential production of human chorionic gonadotropin and free subunits in gestationa...
8776234 - Is isolated second-trimester hyperechogenic bowel a predictor of suboptimal fetal growth?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  141     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1981 Oct 
Date Detail:
Created Date:  1981-11-22     Completed Date:  1981-11-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  237-41     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anemia, Sickle Cell / complications,  therapy*
Exchange Transfusion, Whole Blood*
Female
Fetal Monitoring
Humans
Infant, Newborn
Isoantibodies / biosynthesis
Pregnancy
Pregnancy Complications, Hematologic / therapy*
Prenatal Care
Risk
Chemical
Reg. No./Substance:
0/Isoantibodies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Short-term variability of fetal heart rate in cholestasis of pregnancy.
Next Document:  The epidemiology of neonatal death in twins.